Presented by
Management Forum
Antimicrobial Resistance (AMR) and 'One Health': Current Challenges, Regulatory Frontiers and Future Solutions In-house Training
This course will allow participants to explore the regulatory landscapes governing AMR, discover innovative solutions and understand the challenges AMR poses across different sectors.
- Format: Live online
- CPD: 6 hours for your records
- Certificate of completion
Course overview
Antimicrobial resistance (AMR) has emerged as a daunting global challenge, threatening to undermine decades of medical advancements. It occurs when microorganisms such as bacteria, viruses, fungi, and parasites no longer respond to antimicrobial drugs, rendering treatments ineffective. This phenomenon jeopardises our ability to treat infections, leading to longer illnesses, increased mortality, and soaring healthcare costs. AMR's impact extends beyond human health; it affects veterinary medicine, agriculture, and the environment, creating a complex, interconnected ‘One Health’ crisis.
This comprehensive course delves into the intricacies of antimicrobial resistance (AMR) through the lens of the ‘One Health’ framework. Participants will gain insight into the regulatory landscapes governing AMR, understand the multifaceted challenges posed by AMR across different sectors, and explore innovative solutions, including alternatives to antibiotics like microbiome-derived antimicrobials and policy approaches. The course is designed to foster a holistic understanding of how human, animal, and environmental health are interconnected in the fight against AMR.
This course is part of our Regulatory Affairs Training course collection, which features updates on the latest regulations to registration procedures and strategies.
Benefits of attending
- Gain a thorough understanding of AMR and the ‘One Health’ approach, including regulatory mechanisms and future trends
- Learn about current and emerging regulations related to AMR at national and international levels
- Explore real-world examples of current research and development in alternative treatments and AMR management and discover innovative solutions for tackling this global issue, including cutting-edge research on microbiome-derived antimicrobials, phages and phytogenics
- Participate in Q&A sessions, interactive discussions and case studies, connecting with professionals across various sectors
- Collaborate on developing imaginative solutions and novel approaches to tackle AMR
Who should attend?
- Professionals involved in creating or implementing health and safety regulations
- Doctors, nurses, pharmacists, and other medical staff interested in AMR management
- Those working with animal health and interested in the impact of AMR in veterinary practices
- Individuals focused on the environmental aspects of AMR
- Those studying AMR, ‘One Health’, or related fields
- Pharmaceutical, biopharma and biotech professionals working in drug development, especially in antibiotics and AMR-related products
This course will cover:
Introduction to AMR, 'One Health' and antibiotic resistance
- Fundamental concepts of AMR and the ‘One Health’ framework
- Overview of antibiotic resistance mechanisms
Current regulatory landscape of AMR
- Examination of current regulations and policies on AMR at various levels
- Discussion on the role of regulatory bodies
Cross-sector challenges and strategic approaches
- Challenges in integrating human, animal and environmental health strategies
- Strategic approaches to AMR across sectors
Emerging alternatives to antibiotics, case studies and practical solutions
- Presentation of real-world case studies in AMR management
- Discussion of practical solutions and participant questions
- Exploring alternatives to traditional antibiotics, including microbiome-derived antimicrobials and phytogenics
Exploration of citizen perspectives and utilising science in communities
- Interactive case studies illustrating successful community initiatives
Creative solutions and approaches to tackling AMR
- Discussion on innovative and creative approaches to AMR management using breakout rooms
Linda Oyama
Linda Oyama is a microbiologist and lecturer at the School of Biological Sciences and Institute for Global Food Security, Queen’s University Belfast, with a first-class Microbiology degree and a PhD in Biological Sciences.
Linda’s research interests centre on understanding antimicrobial resistance (AMR) in microbiomes from a ‘One Health; perspective through surveillance and epidemiological studies using meta-omics approaches. She aims to tackle AMR through the discovery and development of novel treatment options for various clinical and veterinary multidrug resistant (MDR) infections.
Linda is a pioneer and executive group member of the UK Young Academy. She leads the AMR Hub at QUB and the Futures AMR Network (FAN), a UKRI funded ‘Transdisciplinary Network to Tackle Antimicrobial Resistance’ across human and livestock systems, whose vision is to harness young talent for innovation in tackling the AMR challenge with the support of world- leading AMR experts. She has an infectious, positive personality and a passion for the support and development of others, being always ready to help.
